In a groundbreaking decision, the FDA has lifted the black box warnings on hormone replacement therapy for menopause, potentially improving access for women seeking relief from menopausal symptoms.
The FDA has removed black box warnings on estrogen treatments for menopause, igniting a debate about the benefits and risks of hormone therapy. Dr. Marty Makary discusses the implications for women's health.
Emma Barnett shares her struggles with perimenopause on her new podcast, revealing feelings of identity loss and the challenges women face during this transition. Tune in for a frank discussion on mental health and well-being.
Isabel Kallman grapples with perimenopause symptoms and the decision to consider hormone therapy. Experts argue that the risks associated with treatment may have been overstated, calling for a reevaluation of FDA warnings.
Doctors are pushing the FDA to remove black box warnings on low-dose estrogen treatments, arguing it discourages women from beneficial hormone therapies for menopause. Experts claim the risks are overstated and can hinder treatment.